Press release
LAGENIO Announces the A12 PRO as the Leading Large-Battery Smartphone for Everyday Use
In today's fast-paced digital world, finding a smartphone that combines long-lasting performance, advanced features, and affordability is a challenge. LAGENIO [https://shop.lagenio.com/] has made this possible with the A12 PRO, a smartphone designed for users who demand power, style, and efficiency in their everyday lives. With its massive battery, high-end display, and advanced camera setup, the A12 PRO is redefining what people expect from a budget-friendly premium device.Powerful Performance with Next-Gen Hardware
The LAGENIO A12 PRO is powered by the T7250 Octa-Core processor clocking up to 1.8GHz, ensuring smooth multitasking and efficient power management. Backed with a massive 24GB RAM (8GB physical + 16GB virtual), it delivers seamless performance whether you're gaming, streaming, or running multiple apps. Coupled with a 256GB ROM, you get ample storage for all your apps, photos, videos, and files without worrying about space.
A Battery That Lasts for Days
One of the standout features of the A12 PRO is its 6500mAh long-lasting battery. With up to 39 hours of talk time and an impressive 1200 hours of standby time, this phone is built for users who don't want to be tied to chargers all day. Whether you're traveling, working, or streaming your favorite shows, the A12 PRO ensures your phone stays powered when you need it most.
Stunning Visual Experience
The smartphone comes with a 6.9-inch HD+ Incell Display, offering a 90% screen-to-body ratio for an immersive viewing experience. Its 120Hz refresh rate ensures smoother scrolling, gaming, and video playback. Watching content on this device is enhanced further with Widevine L1 certification, which guarantees HD-quality streaming on popular platforms.
Advanced AI Cameras for Every Moment
The A12 PRO is equipped with a 50MP AI-enhanced rear camera that captures sharp, detailed photos in all conditions. Features like Night Mode, HDR, Portrait, Panorama, and Face Filters make photography enjoyable and versatile. For selfies and video calls, the 8MP AI Beauty Front Camera ensures clear and vibrant results.
Global Connectivity and Seamless Use
Designed for international use, the A12 PRO supports over 20 global frequency bands, ensuring connectivity wherever you go. With dual Nano SIM + TF card support, dual-band Wi-Fi (2.4GHz / 5GHz), and Bluetooth 5.0, this smartphone keeps you connected at all times. The USB Type-C with OTG further enhances convenience.
Security Made Simple
Security is a priority with the A12 PRO. It features multiple unlock options including PIN, Side Fingerprint Scanner, and Face Unlock, giving users flexibility and peace of mind. Regular OTA updates also ensure improved system stability and quarterly security patches.
Built for Everyday Durability
With its ultra-thin 8.55mm body, weighing just 211g, the LAGENIO A12 PRO is lightweight yet durable. It comes in stylish colors - Navy, Blue, and White - making it a smartphone that looks as premium as it performs.
Product Link
Discover more details and purchase directly here: https://shop.lagenio.com/
Media Contact
Company Name: Tirisen Group
Contact Person: LAGENIO
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=lagenio-announces-the-a12-pro-as-the-leading-largebattery-smartphone-for-everyday-use]
Country: Germany
Website: https://shop.lagenio.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release LAGENIO Announces the A12 PRO as the Leading Large-Battery Smartphone for Everyday Use here
News-ID: 4158937 • Views: …
More Releases from ABNewswire
Genloop Meets Prime Minister Narendra Modi to Advance Vision for Ethical, Scalab …
Genloop leaders met with India's Prime Minister to discuss advancing ethical, scalable AI from innovation to real-world deployment.
Santa Monica, CA - January 14, 2026 - Genloop [https://genloop.ai/?utm_source=ABNews&utm_medium=email&utm_campaign=1752vc], a portfolio company of 1752vc [http://1752.vc/?utm_source=abnews] (formerly Pegasus Angel Accelerator), announced that its leadership met with the Prime Minister of India, Narendra Modi, at his official residence, 7 Lok Kalyan Marg, for a high-level strategic discussion on the future of artificial intelligence in…
Alopecia Areata Market to Witness Promising Upswing by 2034, DelveInsight Foreca …
The Key Alopecia Areata Companies in the market include - Eli Lilly and Company/Incyte Corporation, Pfizer, Legacy Healthcare, Pfizer, Q32 Bio Inc., AbbVie, Amgen, Concert Pharmaceuticals, Bristol-Myers Squibb, Reistone Biopharma, Inmagene LLC, Suzhou Zelgen Biopharma, Nektar Therapeutics, AnaptysBio, Inc., LEO Pharma, Eli Lilly and Company, and others.
The Alopecia Areata market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage…
Neko Case Neon Grey Midnight Green 2026: Affordable Tickets + CITY10 Code for In …
Neko Case's Neon Grey Midnight Green Tour rocks North America in 2026, celebrating her acclaimed Sept 2025 album-first new solo work since 2018-with raw, live-recorded tracks, powerful vocals, and hits like "Hold On, Hold On." Catch her with Des Demonas (East/Midwest) or Destroyer (West) from Jan 8 Montreal to March dates in CO, CA & more!
Neko Case [https://www.capitalcitytickets.com/Neko-Case-Tickets] is embarking on her electrifying Neon Grey Midnight Green Tour in 2026,…
Toogood Gold Expands Footprint, Positioned for High-Impact Growth 2026 Alongside …
Toogood Gold Corp. (TSXV: TGC | OTCQB: TGGCF) reported final drilling assays from its 100%-owned Toogood Gold Project in Newfoundland, delivering results that significantly expand the scale, continuity, and upside potential of its gold discovery heading into 2026.
The Company's 2025 drill program confirmed the Quinlan target as a large, coherent gold system, with gold intersected in all 30 drill holes completed to date. High-grade intervals and visible gold were reported…
More Releases for A12
Bronchitis Market Insights Highlight Expanding Outlook Till 2034, DelveInsight E …
DelveInsight's "Bronchitis Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Bronchitis, historical and forecasted epidemiology as well as the Bronchitis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Bronchitis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Bronchitis Market Forecast
https://www.delveinsight.com/sample-request/bronchitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key facts of the Bronchitis…
Supreme Dumplings Expands to Texas with First Location in Katy
Authentic Taiwanese Xiao Long Bao Arrives in the Heart of Texas
Image: https://www.abnewswire.com/upload/2025/10/fc222322c0dcd5bb20cef972223984b8.jpg
October 17, 2025 - Katy, TX - Supreme Dumplings, a renowned destination for handcrafted Xiao Long Bao and authentic Taiwanese cuisine, proudly announces the grand opening of its first Texas location in Katy. Following its success in Seattle and San Francisco, Supreme Dumplings continues its mission to bring the artistry, flavor, and warmth of Taiwanese dining to new communities…
Respiratory Syncytial Virus Pipeline Drugs 2025 Report: Emerging Drugs, Innovati …
DelveInsight's, "Respiratory Syncytial Virus Pipeline Insight 2025" report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in Respiratory Syncytial Virus (RSV) pipeline landscape. It covers the Respiratory Syncytial Virus pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Respiratory Syncytial Virus pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Discover…
Respiratory Syncytial Virus Pipeline Outlook 2025: Clinical Trial Studies, EMA, …
DelveInsight's, "Respiratory Syncytial Virus Pipeline Insight 2025" report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in Respiratory Syncytial Virus (RSV) pipeline landscape. It covers the Respiratory Syncytial Virus pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Respiratory Syncytial Virus pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Discover…
Respiratory Syncytial Virus Clinical Trials and Studies 2025: EMA, PDMA, FDA App …
DelveInsight's, "Respiratory Syncytial Virus Pipeline Insight 2025" report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in Respiratory Syncytial Virus (RSV) pipeline landscape. It covers the Respiratory Syncytial Virus pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Respiratory Syncytial Virus pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Discover…
Pancreatic Cancer Market to Progress at a CAGR of 7.3 % by 2032 | DelveInsight
DelveInsight's Pancreatic Cancer Market Insights report includes a comprehensive understanding of current treatment practices, pancreatic cancer emerging drugs, market share of individual therapies, and current and forecasted market size from 2019 to 2032, segmented into 7MM (the United States, the EU5 (the United Kingdom, Italy, Spain, France, and Germany), and Japan.
The pancreatic cancer market is anticipated to show positive growth, mainly attributed to the increasing incident cases and also, the…
